- Home
- Shop
- Research Peptides
- Tesamorelin – 10mg
Tesamorelin – 10mg
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
$80.00
Availability:
32 in stock
Ships today. Additional quantities may be backordered. Backordered items ship in 7-10 business days.
Retatrutide 20 mg — precision-manufactured triple receptor agonist for metabolic and energy homeostasis research.
Sequence
Mod-GR(1-29)
CAS Number
2381089-83-2
Purity
99.8%
Format
Lyophilized powder
Lot Number
AET-5-AMINO-50MG-09472
Purity (HPLC)
99.8%
Molecular Mass
4732.2 Da
Test Method
HPLC + Mass Spectrometry
Verified
Independent laboratory
Store lyophilized peptides at -20°C upon receipt. Reconstitute with bacteriostatic water and aliquot to avoid repeated freeze-thaw cycles. Reconstituted solutions should be stored at 2–8°C for short-term use or -20°C for long-term storage. Protect from light.
You May Also Like
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.8% Purity
Research Peptides
Retatrutide 20 mg — precision-manufactured triple receptor agonist for metabolic and energy homeostasis research.
